Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice
Maria Luisa Brandi1, Carolina R C Pieterman2, Katherine A English3
1Fondazione FIRMO Onlus (Italian Foundationfor the Research on Bone Diseases), Florence, Italy; Endocrinology Unit, IRCCS San Raffaele Hospital, Milan, Italy.
Multiple endocrine neoplasia type 1 (MEN1) management guidelines are now available. These recommendations aid in early tumor detection and intervention, improving patient outcomes for this rare genetic disorder.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder.
- MEN1 is characterized by parathyroid, duodenopancreatic neuroendocrine, and pituitary tumors.
- MEN1 mutations in the MEN1 gene lead to high morbidity and mortality without early intervention.
Purpose of the Study:
- To develop evidence-based clinical recommendations for MEN1 assessment and management.
- To provide guidance for clinicians, patients, and stakeholders involved in MEN1 care.
- To address the lack of consensus on optimal MEN1 approaches.
Main Methods:
- Systematic literature reviews and meta-analysis.
- Delphi approach for consensus development.
- Multidisciplinary expert group convened.
Main Results:
- 55 clinical recommendations were developed.
- Recommendations cover assessment and management strategies for MEN1.
- Guidelines are applicable to both adult and pediatric patients.
Conclusions:
- The developed recommendations aim to optimize MEN1 patient care.
- Early detection and intervention are crucial for mitigating MEN1 morbidity and mortality.
- Standardized guidelines will improve the management of this rare endocrine neoplasia syndrome.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023